share_log

RIV Capital Reports YoY Increase In Q1 Revenue, Gross Profit Ahead Of Merger With Cansortium To Create Four-State Cannabis Company

RIV Capital Reports YoY Increase In Q1 Revenue, Gross Profit Ahead Of Merger With Cansortium To Create Four-State Cannabis Company

RIV Capital报告称,在与Cansortium合并创建四州大麻公司之前,第一季度收入和毛利同比增长
Benzinga ·  05/31 11:30

Cannabis-focused acquisition and investment firm RIV Capital Inc. (CSE:RIV) (OTC:CNPOF) released its financial results on Thursday for the first quarter ended March 31, 2024.

大麻股收购和投资公司RIV Capital Inc. (CSE:RIV) (场外交易:CNPOF)在周四发布了截至2024年3月31日的第一季度财务业绩。

Mike Totzke, the company's COO and interim CEO, called the first quarter "pivotal" referring to the official launch of the company's recreational cannabis operations in New York. The company opened its first adult-use dispensary in White Plains.

公司首席运营官兼临时首席执行官Mike Totzke称第一季度是“关键时期”,这是指新近获得纽约州的休闲大麻运营牌照。公司在怀特普莱恩斯开设了第一家成人用途的药店。

"Following years of hard work, we are incredibly proud of our entire team for their dedication, which enabled us to take this transformative step forward," Totzke said. "The growth we have seen at our newly launched White Plains dispensary is well in line with our expectations and customer feedback has been fantastic."

"经过多年的艰苦努力,我们为整个团队的奉献感到无比自豪,这使我们得以迈出这一变革性的步伐," Totzke说。"我们新开设的怀特普莱恩斯诊所的增长完全符合我们的预期,顾客回馈也非常好。"

The first quarter earnings announcement comes on the heels of the announced merger of RIV Capital and Cansortium Inc., a multi-state cannabis operator under the FLUENT brand. The combined company will operate in Florida, New York, Texas, and Pennsylvania, covering 25% of the U.S. population with eight cultivation and processing facilities and 42 retail dispensaries.

这份第一季度业绩公告是在RIV Capital与FLUENT品牌下的多州大麻运营商Cansortium Inc.宣布合并之后发布的。合并后的公司将在佛罗里达、纽约、得克萨斯和宾夕法尼亚州运营,共拥有8个种植和加工设施以及42家零售分店,覆盖了美国25%的人口。

See also: Revenue Growth And Cannabis Market Expansion: RIV Capital's Fiscal Highlights For 2023

另见: RIV Capital 2023财年营收增长和大麻市场扩张

As yet another earnings reporting season wraps up it is important to understand what these figures mean for the future of the industry. Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.

随着另一个季度的财报发布结束,了解这些数字对该行业的未来意味着什么是很重要的。在即将于10月8日至9日举行的第19届博鳌亚洲论坛上,直接听取高管、投资者和决策者的意见。立即按照此链接购买门票,以避免价格上涨。

Q1 2024 Financial Highlights

2024年第一季度财务亮点

  • Net revenue was $2.1 million, compared to $1.7 million for the same period of 2023.
  • Gross profit was $613 000, up from $212 000 in the first quarter of last year.
  • The cost of goods sold was $1.9 million, compared to $1.6 million for the first quarter of last year.
  • Selling, general, and administrative expenses were $6.2 million for the period, compared to $5.3 million in the prior year's period.
  • Operating loss was $5.6 million, up from $5.1 million in the corresponding period of 2023.
  • Net loss was roughly $5 million, down from $23.6 million in the first quarter of the prior year.
  • 净营收为210万美元,与2023年同期的170万美元相比有所增加。
  • 毛利润为61.3万美元,高于去年第一季度的21.2万美元。
  • 营业成本为190万美元,与去年第一季度的160万美元相比有所增加。
  • 销售、管理和行政费用为620万美元,相比上一年期间的530万美元有所增加。
  • 运营亏损为560万美元,高于2023年对应期的510万美元。
  • 净损失约为500万美元,低于去年第一季度的2360万美元。

CNPOF Price Action

CNPOF价格走势

RIV Capital's shares traded 3.9738% higher at $0.1347 per share at the time of writing on Friday morning.

截至星期五早上撰写本文时,RIV Capital的股票价格为每股0.1347美元,上涨了3.9738%。

Related News

相关新闻资讯

  • RIV Capital Reports YoY Revenue Growth In Q2, Plans To Establish Dominant Role In New York Wholesale Market
  • RIV Capital Q4 FY23 Revenue Declines 10.5% Hit By Illicit Market And Statewide Decline In Medical Cannabis Sales
  • Riv Capital Stock Trading Higher On Stagnating Q3 FY23 Revenue And CEO Departing
  • RIV Capital报告了季度营收增长,计划在纽约批发市场中建立主导地位
  • RIV Capital Q4 FY23营收下降10.5%,受非法市场和医用大麻销售下滑影响
  • Riv Capital股票交投上升,Q3 FY23营收趋稳和CEO离职
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发